Compare Stocks: BLCO, WST, SOLV, and COO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLCO Bausch + Lomb	$16.79 -0.7%	$15.93	$13.53 ▼ $18.92	$5.99B	0.56	434,882 shs	429,056 shs
COO Cooper Companies	$74.23 +2.6%	$68.36	$58.89 ▼ $89.83	$14.48B	0.84	2.42 million shs	2.81 million shs
SOLV Solventum	$87.95 +2.9%	$78.41	$62.38 ▼ $88.65	$15.23B	0.66	1.41 million shs	1.29 million shs
WST West Pharmaceutical Services	$347.76 +2.0%	$339.80	$223.83 ▼ $386.00	$24.47B	1.16	911,908 shs	643,100 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLCO Bausch + Lomb	0.00%	+4.02%	-1.97%	+3.57%	+24.95%
COO Cooper Companies	0.00%	+2.86%	-2.53%	+15.97%	+2.05%
SOLV Solventum	0.00%	+9.84%	+9.56%	+28.31%	+19.47%
WST West Pharmaceutical Services	0.00%	+3.78%	-6.79%	+13.47%	+42.61%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLCO Bausch + Lomb	$16.79 -0.7%	$15.93	$13.53 ▼ $18.92	$5.99B	0.56	434,882 shs	429,056 shs
COO Cooper Companies	$74.23 +2.6%	$68.36	$58.89 ▼ $89.83	$14.48B	0.84	2.42 million shs	2.81 million shs
SOLV Solventum	$87.95 +2.9%	$78.41	$62.38 ▼ $88.65	$15.23B	0.66	1.41 million shs	1.29 million shs
WST West Pharmaceutical Services	$347.76 +2.0%	$339.80	$223.83 ▼ $386.00	$24.47B	1.16	911,908 shs	643,100 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLCO Bausch + Lomb	0.00%	+4.02%	-1.97%	+3.57%	+24.95%
COO Cooper Companies	0.00%	+2.86%	-2.53%	+15.97%	+2.05%
SOLV Solventum	0.00%	+9.84%	+9.56%	+28.31%	+19.47%
WST West Pharmaceutical Services	0.00%	+3.78%	-6.79%	+13.47%	+42.61%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLCO Bausch + Lomb	2.29	Hold	$18.75	11.68% Upside
COO Cooper Companies	2.35	Hold	$81.36	9.60% Upside
SOLV Solventum	2.46	Hold	$86.00	-2.22% Downside
WST West Pharmaceutical Services	3.00	Buy	$368.08	5.84% Upside

Current Analyst Ratings Breakdown

Latest BLCO, WST, SOLV, and COO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/3/2026	WST West Pharmaceutical Services	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$400.00 ➝ $412.00
8/3/2026	BLCO Bausch + Lomb	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$20.00 ➝ $21.00
7/30/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/28/2026	SOLV Solventum	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$95.00
7/28/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/28/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/28/2026	COO Cooper Companies	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$75.00
7/27/2026	WST West Pharmaceutical Services	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$425.00
7/24/2026	BLCO Bausch + Lomb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/24/2026	WST West Pharmaceutical Services	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
7/17/2026	SOLV Solventum	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)

(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLCO Bausch + Lomb	$5.32B	1.13	$1.66 per share	10.14	$18.40 per share	0.91
COO Cooper Companies	$4.23B	3.42	$6.22 per share	11.94	$41.44 per share	1.79
SOLV Solventum	$8.26B	1.84	$9.25 per share	9.51	$29.11 per share	3.02
WST West Pharmaceutical Services	$3.33B	7.36	$9.93 per share	35.02	$44.10 per share	7.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLCO Bausch + Lomb	-$360M	-$0.48	N/A	15.84	0.52	-3.21%	4.14%	1.93%	N/A
COO Cooper Companies	$374.90M	$1.18	62.91	14.88	1.89	5.57%	10.88%	7.27%	9/9/2026 (Estimated)
SOLV Solventum	$1.56B	$8.16	10.78	12.39	1.32	17.33%	23.51%	7.63%	8/5/2026 (Estimated)
WST West Pharmaceutical Services	$493.70M	$7.81	44.53	35.23	2.38	16.98%	20.11%	14.83%	10/22/2026 (Estimated)

Latest BLCO, WST, SOLV, and COO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	SOLV Solventum	$1.90	N/A	N/A	N/A	$2.15 billion	N/A
7/23/2026	Q2 2026	WST West Pharmaceutical Services	$2.08	$2.37	+$0.29	$2.15	$839.98 million	$872.30 million
6/4/2026	Q2 2026	COO Cooper Companies	$1.10	$1.21	+$0.11	-$0.40	$1.05 billion	$1.08 billion
5/5/2026	Q1 2026	SOLV Solventum	$1.35	$1.48	+$0.13	$0.07	$1.97 billion	$2.01 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLCO Bausch + Lomb	N/A	N/A	N/A	N/A	N/A
COO Cooper Companies	N/A	N/A	-100.00%	N/A	N/A
SOLV Solventum	N/A	N/A	N/A	N/A	N/A
WST West Pharmaceutical Services	$0.88	0.25%	+5.51%	11.27%	N/A

Latest BLCO, WST, SOLV, and COO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/21/2026	WST West Pharmaceutical Services	quarterly	$0.22	0.26%	7/29/2026	7/29/2026	8/5/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLCO Bausch + Lomb	0.79	1.55	1.02
COO Cooper Companies	0.23	1.27	0.78
SOLV Solventum	0.96	1.07	0.75
WST West Pharmaceutical Services	0.07	2.82	2.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLCO Bausch + Lomb	11.07%
COO Cooper Companies	24.39%
SOLV Solventum	N/A
WST West Pharmaceutical Services	93.90%

Insider Ownership

Company	Insider Ownership
BLCO Bausch + Lomb	1.45%
COO Cooper Companies	2.08%
SOLV Solventum	0.24%
WST West Pharmaceutical Services	0.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLCO Bausch + Lomb	13,000	357.06 million	351.88 million	Optionable
COO Cooper Companies	15,000	195.03 million	190.97 million	Optionable
SOLV Solventum	20,000	173.18 million	172.76 million	Optionable
WST West Pharmaceutical Services	10,800	70.38 million	69.95 million	Optionable

BLCO, WST, SOLV, and COO Headlines

Recent News About These Companies

Is Stronger Q2 Results, Raised Outlook and Buybacks Altering The Investment Case For West Pharmaceutical Services (WST)?

2 hours ago | uk.finance.yahoo.com

West Pharmaceutical Services, Inc. $WST Stock Position Trimmed by The Manufacturers Life Insurance Company

August 3 at 5:12 AM | marketbeat.com

Cetera Investment Advisers Sells 6,077 Shares of West Pharmaceutical Services, Inc. $WST

August 3 at 3:36 AM | marketbeat.com

West Pharmaceutical Services, Inc. $WST Holdings Increased by First Trust Advisors LP

August 3 at 3:35 AM | marketbeat.com

California State Teachers Retirement System Has $27.73 Million Position in West Pharmaceutical Services, Inc. $WST

August 2 at 3:43 AM | marketbeat.com

Royal Bank of Canada Sells 67,308 Shares of West Pharmaceutical Services, Inc. $WST

August 1 at 5:59 AM | marketbeat.com

Amundi Has $161.43 Million Holdings in West Pharmaceutical Services, Inc. $WST

August 1 at 3:10 AM | marketbeat.com

Liontrust Investment Partners LLP Decreases Stake in West Pharmaceutical Services, Inc. $WST

July 31 at 6:23 AM | marketbeat.com

Quantinno Capital Management LP Increases Stock Holdings in West Pharmaceutical Services, Inc. $WST

July 31 at 5:21 AM | marketbeat.com

West Pharmaceutical Services, Inc. $WST Holdings Increased by Dimensional Fund Advisors LP

July 29, 2026 | marketbeat.com

Healthcare of Ontario Pension Plan Trust Fund Has $12.66 Million Stake in West Pharmaceutical Services, Inc. $WST

July 28, 2026 | marketbeat.com

Weiss Asset Management LP Invests $1.99 Million in West Pharmaceutical Services, Inc. $WST

July 27, 2026 | marketbeat.com

Renaissance Technologies LLC Has $52.55 Million Stock Position in West Pharmaceutical Services, Inc. $WST

July 27, 2026 | marketbeat.com

West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan

July 26, 2026 | finance.yahoo.com

West Pharmaceutical Services, Inc. $WST Shares Acquired by Bank of Nova Scotia

July 26, 2026 | marketbeat.com

Arrowstreet Capital Limited Partnership Purchases 210,112 Shares of West Pharmaceutical Services, Inc. $WST

July 26, 2026 | marketbeat.com

West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV

July 25, 2026 | marketbeat.com

Epoch Investment Partners Inc. Acquires 39,745 Shares of West Pharmaceutical Services, Inc. $WST

July 25, 2026 | marketbeat.com

West Pharmaceutical Services (NYSE:WST) Hits New 52-Week High After Earnings Beat

July 25, 2026 | americanbankingnews.com

West Pharmaceutical Services, Inc. Q2 2026 Earnings Call Summary

July 24, 2026 | finance.yahoo.com

West Pharmaceutical Services Slides as Investors Digest a Post-Earnings Surge

July 24, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BLCO, WST, SOLV, and COO Company Descriptions

Bausch + Lomb NYSE:BLCO

$16.79 -0.12 (-0.72%)

Closing price 03:59 PM Eastern

Extended Trading

$16.75 -0.04 (-0.23%)

As of 04:46 PM Eastern

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

Cooper Companies NASDAQ:COO

$74.23 +1.91 (+2.64%)

Closing price 04:00 PM Eastern

Extended Trading

$74.19 -0.04 (-0.05%)

As of 06:13 PM Eastern

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Solventum NYSE:SOLV

$87.95 +2.51 (+2.94%)

Closing price 03:59 PM Eastern

Extended Trading

$88.04 +0.09 (+0.11%)

As of 05:48 PM Eastern

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

West Pharmaceutical Services NYSE:WST

$347.76 +6.80 (+1.99%)

Closing price 03:59 PM Eastern

Extended Trading

$347.50 -0.25 (-0.07%)

As of 05:50 PM Eastern

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BLCO, WST, SOLV, and COO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BLCO, WST, SOLV, and COO Earnings

Compare Dividends

Latest BLCO, WST, SOLV, and COO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BLCO, WST, SOLV, and COO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BLCO, WST, SOLV, and COO Company Descriptions

Bausch + Lomb NYSE:BLCO

Cooper Companies NASDAQ:COO

Solventum NYSE:SOLV

West Pharmaceutical Services NYSE:WST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools